IND Submission and FDA Approval Strategy
Blog

From Preclinical Data to IND Filing: BioBoston’s Strategic Approach to Drug Development Success

The journey from preclinical research to an Investigational New Drug (IND) filing marks a pivotal phase in drug development. For […]